Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Piperacillin × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 817 Radiotherapy 746 Cisplatin 640 Gemcitabine 565 Carboplatin 527 Docetaxel 523 Paclitaxel 512 Bevacizumab 494 Fluorouracil 440 Rituximab 396 Capecitabine 392 Oxaliplatin 389 Surveys and Questionnaires 380 Dexamethasone 374 Doxorubicin 369 Etoposide 357 Irinotecan 340 Cytarabine 325 Filgrastim 324 pembrolizumab 271 Leucovorin 266 Melphalan 259 fludarabine phosphate 251 Magnetic Resonance Spectroscopy 249 Nivolumab 245 Blood Specimen Collection 242 Peripheral Blood Stem Cell Transplantation 236 Lenalidomide 235 Cetuximab 232 Bortezomib 230

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡